Skip to main content

A New Human Reference Genome Represents the Most Common Sequences

Researchers create a “consensus genome” that halves the number of errors when mapping transcripts, although they say the current standard is still a good tool.

Written byAshleen Knutsen
| 4 min read
consensus genome human reference genome pangenome dna genetics diversity

Register for free to listen to this article
Listen with Speechify
0:00
4:00

ABOVE: © ISTOCK.COM,
NOBI_PRIZUE

The human reference genome is a DNA blueprint used as a standard for comparison in basic research and clinical settings. Despite improvements in accuracy and completeness that have been made over the years, it still harbors limitations that can result in erroneous findings.

In the current version of the reference, called GRCh38 or Build 38, 93 percent of the sequence comes from just 11 individuals and 70 percent from just one man, resulting in a lack of diversity and at least 300 million missing letters of DNA. In addition, a small percentage of the genes in the reference genome are represented by alleles that are not the most common forms of the genes.

To address these issues, some scientists are developing a new reference, called the pangenome or graph genome, that contains a vast collection of genomes representing all possible DNA sequences for any given locus. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related Topics

November digest cover
November 2026

Chemistry Meets Arcade Combat in “Reaction Rumble” Game

Choose your fighter! Enter the arena as chemical elements and dole out moves inspired by real-world reactions in this educational browser-based game.

View this Issue
From Pilot to Practice: Advancing Regulatory Reliance

From Pilot to Precedent: A Year of Regulatory Innovation through PRISM and What it Means for Cloud Adoption in Regulatory Submissions

DNAnexus
Thumbnail

Make It Local, Make It Last: The Evolution of mRNA Protein Replacement Therapy

Improving Western Blot Analysis of Biofluid Samples

Improving Western Blot Analysis of Biofluid Samples

Bio-Rad
Reducing AAV Sample Consumption With Multiwavelength SV-AUC

Reducing AAV Sample Consumption With Multiwavelength SV-AUC

​Beckman Coulter

Products

Sino Biological Logo

Sino Biological Advances AI-Designed Molecule Validation with 4RISE™

Abstract image of circles and concentric lines on a blue and pink background.

MX Analytical and Precision Balances: Effortless Weighing and Secure Data Handling

Mettler
3D multicolored conceptual image of antibody molecules

Premium BsAb: LC-MS-Assisted Bispecific Antibody Production with >98% Heterodimer Purity

WuXi Biologics
Abstract conceptual image of AI technology for medical science research.

Exploring a New Era of Pharmaceutical Innovation